Back
Keros Therapeutics Stock Price Chart

How He Bagged One Of The Top Trading Records
Click HERE to see how he's done it
Sell
49
KROS
Keros Therapeutics
Last Price:
42.08
Seasonality Move:
-32.26%
7 Day Trial
ALL ACCESS PASS
$
7

Adam Mesh: "This Strategy Saved My Trading Career"
Click here to let Adam show you how it's done.- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and KROS is experiencing slight buying pressure.
Keros Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 42.49 | Buy |
20-day SMA: | 46.21 | Sell |
50-day SMA: | 51.4 | Sell |
200-day SMA: | 42.82 | Buy |
8-day EMA: | 42.82 | Buy |
20-day EMA: | 45.48 | Sell |
50-day EMA: | 48.5 | Sell |
200-day EMA: | 46.7 | Sell |
Keros Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -2.87 | Sell |
Relative Strength Index (14 RSI): | 40.22 | Sell |
Chaikin Money Flow: | 42094 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (42.2 - 53.24) | Sell |
Bollinger Bands (100): | (44.93 - 54.25) | Sell |
Keros Therapeutics Technical Analysis
Mar-16 | Mar-17 | Mar-20 | Mar-21 | Mar-22 | Mar-23 | Mar-24 | Mar-27 | Mar-28 | Mar-29 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | ||||||||||
16 | 17 | 20 | 21 | 22 | 23 | 24 | 27 | 28 | 29 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Keros Therapeutics Stock
Is Keros Therapeutics Stock a Buy?
- Keros Therapeutics share price is 43.49 while KROS 8-day simple moving average is 42.49, which is a Buy signal.
- The stock price of KROS is 43.49 while Keros Therapeutics 20-day SMA is 46.21, which makes it a Sell.
- Keros Therapeutics 50-day simple moving average is 51.40 while KROS share price is 43.49, making it a Sell technically.
- KROS stock price is 43.49 and Keros Therapeutics 200-day simple moving average is 42.82, creating a Buy signal.
KROS Technical Analysis vs Fundamental Analysis
Sell
49
Keros Therapeutics (KROS)
is a Sell
Is Keros Therapeutics a Buy or a Sell?
-
Keros Therapeutics stock is rated a Sell
The current Keros Therapeutics [KROS] share price is $43.49. The Score for KROS is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
Keros Therapeutics Stock Info
Market Cap:
1.24B
Price in USD:
43.49
Share Volume:
165.02K
Keros Therapeutics 52-Week Range
52-Week High:
68.29
52-Week Low:
24.38
Sell
49
Keros Therapeutics (KROS)
is a Sell
Keros Therapeutics Share Price Forecast
-
What is the Keros Therapeutics stock price today?
The Keros Therapeutics stock price is 43.49 USD today. -
Will KROS stock go up or go down?
Keros Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Keros Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Keros Therapeutics is overvalued.
Is Keros Therapeutics Stock a Buy?
- Keros Therapeutics share price is 43.49 while KROS 8-day exponential moving average is 42.82, which is a Buy signal.
- The stock price of KROS is 43.49 while Keros Therapeutics 20-day EMA is 45.48, which makes it a Sell.
- Keros Therapeutics 50-day exponential moving average is 48.50 while KROS share price is 43.49, making it a Sell technically.
- KROS stock price is 43.49 and Keros Therapeutics 200-day simple moving average is 46.70, creating a Sell signal.
Fundamental Analysis of Keros Therapeutics
Is Keros Therapeutics a good investment?
- Analysts estimate an earnings decrease this quarter of $0.09 per share, a decrease next quarter of $0.03 per share, a decrease this year of $0.49 per share, and a decrease next year of $0.36 per share.
Technical Analysis of Keros Therapeutics
Should I short Keros Therapeutics stock?
- KROS Moving Average Covergence Divergence (MACD) indicator is -2.87, suggesting Keros Therapeutics is a Sell
- Keros Therapeutics Relative Strength Index (RSI) is 40.22, which suggest Keros Therapeutics is oversold
- The Bollinger Bands (25) for Keros Therapeutics is (42.2 - 53.24), which suggest Keros Therapeutics is a Sell
- The Bollinger Bands (100) for Keros Therapeutics is (44.93 - 54.25), which suggest Keros Therapeutics is a Sell
* Keros Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.